Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of european ancestry

Human Molecular Genetics

Volumn 25, Issue 6, 2015, Pages 1203-1214

  Figueroa, Jonine D ^a,b   Middlebrooks, Candace D ^a   Banday, A Rouf ^a   Ye, Yuanqing ^c   Garcia Closas, Montserrat ^a,d   Chatterjee, Nilanjan ^a   Koutros, Stella ^a   Kiemeney, Lambertus A ^e   Rafnar, Thorunn ^f   Bishop, Timothy ^g   Furberg, Helena ⁱ   Matullo, Giuseppe ^l,m   Golka, Klaus ⁿ   Gago Dominguez, Manuela ^o   Taylor, Jack A ^p   Fletcher, Tony ^q   Siddiq, Afshan ^r   Cortessis, Victoria K ^i,s,t   Kooperberg, Charles ^u   Cussenot, Olivier ^i,x,y   Benhamou, Simone ^z,aa   Prescott, Jennifer ^ab,ac   Porru, Stefano ^ad   Dinney, Colin P ^c   Malats, Núria ^ae   Baris, Dalsu ^a   Purdue, Mark P ^a   Jacobs, Eric J ^af   Albanes, Demetrius ^a   Wang, Zhaoming ^a   Chung, Charles C ^a,c   Vermeulen, Sita H ^e   Aben, Katja K ^e   Galesloot, Tessel E ^e   Thorleifsson, Gudmar ^f   Sulem, Patrick ^f   Stefansson, Kari ^f,ag   Kiltie, Anne E ^ah   Harland, Mark ^g   Teo, Mark ^h   Offit, Kenneth ⁱ   Vijai, Joseph ⁱ   Bajorin, Dean ^j   Kopp, Ryan ^k   Fiorito, Giovanni ^l,m   Guarrera, Simonetta ^l,m   Sacerdote, Carlotta ^ai   Selinski, Silvia ⁿ   Hengstler, Jan G ⁿ   Gerullis, Holger ^i,aj   Ovsiannikov, Daniel ^ak   Blaszkewicz, Meinolf ⁿ   Castelao, Jose Esteban ^al   Calaza, Manuel ^o,am   Martinez, Maria Elena ^an   Cordeiro, Patricia ^ao   Xu, Zongli ^p   Panduri, Vijayalakshmi ^p   Kumar, Rajiv ^ap,by   Gurzau, Eugene ^aq   Koppova, Kvetoslava ^ar   Bueno De Mesquita, H Bas ^r,as,at   Ljungberg, Börje ^au   Clavel Chapelon, Françoise ^av,aw,ax   Weiderpass, Elisabete ^ay,az,ba,bb   Krogh, Vittorio ^bc   Dorronsoro, Miren ^bd,be   Travis, Ruth C ^ah   Tjønneland, Anne ^bf   Brennan, Paul ^bg   Chang Claude, Jenny ^ap,by   Riboli, Elio ^r   Conti, David ^i,r   Stern, Marianna C ^i,r   Pike, Malcolm C ^g   Van Den Berg, David ^i,r   Yuan, Jian Min ^bh   Hohensee, Chancellor ^u   Jeppson, Rebecca P ^u   Cancel Tassin, Geraldine ^x,y   Roupret, Morgan ^v,x,y   Comperat, Eva ^w,x,y   Turman, Constance ^ac   De Vivo, Immaculata ^t,ab   Giovannucci, Edward ^ab,ac   Hunter, David J ^ab,ac,bi   Kraft, Peter ^ac   Lindstrom, Sara ^ac   Carta, Angela ^ad   Pavanello, Sofia ^bj   Arici, Cecilia ^ad   Mastrangelo, Giuseppe ^bj   Kamat, Ashish M ^c   Zhang, Liren ^c   Gong, Yilei ^c   Pu, Xia ^c   Hutchinson, Amy ^a   Burdett, Laurie ^a   Wheeler, William A ^bk   Karagas, Margaret R ^bl   Johnson, Alison ^bm   Schned, Alan ^bl   Monawar Hosain, G M ^bn   Schwenn, Molly ^bo   Kogevinas, Manolis ^be,bp,bq,br   Tardón, Adonina ^be,bs   Serra, Consol ^be,bq,bt   Carrato, Alfredo ^bu   García Closas, Reina ^bv   Lloreta, Josep ^be   Andriole, Gerald ^bw   Robert, Grubb ^bw   Black, Amanda ^a   Diver, W Ryan ^af   Gapstur, Susan M ^af   Weinstein, Stephanie ^a   Virtamo, Jarmo ^bx   Haiman, Christopher A ⁱ   Landi, Maria Teresa ^a   Caporaso, Neil E ^a   Joseph, Fraumeni ^a   Vineis, Paolo ^m,r   Wu, Xifeng ^c   Chanock, Stephen J ^a   Silverman, Debra T ^a   Prokunina Olsson, Ludmila ^a   Rothman, Nathaniel ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f DECODE GENETICS   (Iceland)

^g UNIVERSITY OF LEEDS   (United Kingdom)

^h UNIVERSITY OF LEEDS   (United Kingdom)

ⁱ Department of Medicine ^*  (Germany)

^j Gastrointestinal Oncology Solid Tumor Service   (United States)

^k MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^l UNIVERSITY OF TURIN   (Italy)

^m Human Genetics Foundation   (Italy)

ⁿ LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^o UNIVERSITY OF VIGO   (Spain)

^p NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^q LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^r IMPERIAL COLLEGE LONDON   (United Kingdom)

^s UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^t UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^u Fred Hutchinson Cancer Research Center   (United States)

^v PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^w ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^x CeRePP Group   (France)

^y SORBONNE UNIVERSITÉ   (France)

^z FONDATION JEAN DAUSSET CEPH   (France)

^aa Gustave Roussy Comprehensive Cancer Institute   (France)

^ab BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ac HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^ad UNIVERSITY OF BRESCIA   (Italy)

^ae Centro Nacional de Investigaciones Oncológicas   (Spain)

^af AMERICAN CANCER SOCIETY   (United States)

^ag UNIVERSITY OF ICELAND   (Iceland)

^ah UNIVERSITY OF OXFORD   (United Kingdom)

^ai CPO Piemonte   (Italy)

^aj UNIVERSITY OF OLDENBURG   (Germany)

^ak St Josefs Hospital   (Germany)

^al Xerencia de Xestion Integrada de Vigo SERGAS   (Spain)

^am Carl von Ossietzky University Oldenburg ^*  (Spain)

^an UNIVERSITY OF CALIFORNIA   (United States)

^ao HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^ap GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^aq Environmental Health Center   (Romania)

^ar State Health Institute   (Slovakia)

^as NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^at UNIVERSITY OF MALAYA   (Malaysia)

^au UMEÅ UNIVERSITY   (Sweden)

^av INSERM   (France)

^aw UNIVERSITÉ PARIS SACLAY   (France)

^ax INSTITUT GUSTAVE ROUSSY   (France)

^ay UNIVERSITY OF TROMSØ   (Norway)

^az KAROLINSKA INSTITUTE   (Sweden)

^ba CANCER REGISTRY OF NORWAY   (Norway)

^bb FOLKHÄLSAN RESEARCH CENTER   (Finland)

^bc NATIONAL CANCER INSTITUTE   (Italy)

^bd BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^be CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^bf DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^bg INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^bh UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^bi BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^bj UNIVERSITY OF PADOVA   (Italy)

^bk INFORMATION MANAGEMENT SERVICES INC   (United States)

^bl DARTMOUTH MEDICAL SCHOOL   (United States)

^bm Vermont Cancer Registry   (United States)

^bn New Hampshire Cancer Registry   (United States)

^bo Maine Cancer Registry   (United States)

^bp CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^bq HOSPITAL DEL MAR   (Spain)

^br NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^bs UNIVERSITY OF OVIEDO   (Spain)

^bt UNIVERSITAT POMPEU FABRA   (Spain)

^bu HOSPITAL RAMÓN Y CAJAL   (Spain)

^bv HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^bw WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bx NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^by UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CHROMOSOME 13Q; CHROMOSOME 20P; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE BLADDER CANCER; NON MUSCLE INVASIVE BLADDER CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; BLADDER TUMOR; CASE CONTROL STUDY; CAUCASIAN; CHROMOSOME 13; CHROMOSOME 20; ETHNOLOGY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; META ANALYSIS; RISK FACTOR;

TUMOR MARKER;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 20; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84960105525     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv492     Document Type: Article

References (42)

1. Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C. and Parkin, D.M. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
2. Silverman, D.T., Devessa, S.S., Moore, L. and Rothman, N. (2006) In: Fraumeni, J.F. Jr. and Schottenfeld, D. (eds), Cancer Epidemiology and Prevention Third Edition. Oxford University Press, New York, NY, pp. 1101-1127.
3. Kantor, A.F., Hartge, P., Hoover, R.N. and Fraumeni, J.F. Jr. (1985) Familial and environmental interactions in bladder cancer risk. Int. J. Cancer, 35, 703-706.
4. Murta-Nascimento, C., Silverman, D.T., Kogevinas, M., Garcia-Closas, M., Rothman, N., Tardon, A., Garcia-Closas, R., Serra, C., Carrato, A., Villanueva, C. et al. (2007) Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol. Biomarkers Prev., 16, 1595-1600.
5. Plna, K. and Hemminki, K. (2001) Familial bladder cancer in the National Swedish Family Cancer Database. J. Urol., 166, 2129-2133.
6. Dong, C. and Hemminki, K. (2001) Modification of cancer risks in offspring by sibling and parental cancers from 2, 112, 616 nuclear families. Int. J. Cancer, 92, 144-150.
7. Garcia-Closas, M., Malats, N., Silverman, D., Dosemeci, M., Kogevinas, M., Hein, D.W., Tardon, A., Serra, C., Carrato, A., Garcia-Closas, R. et al. (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results fromthe Spanish Bladder Cancer Study andmeta-analyses. Lancet, 366, 649-659.
8. Garcia-Closas, M., Ye, Y., Rothman, N., Figueroa, J.D., Malats, N., Dinney, C.P., Chatterjee, N., Prokunina-Olsson, L., Wang, Z., Lin, J. et al. (2011)Agenome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum. Mol. Genet., 20, 4282-4289.
9. Kiemeney, L.A., Thorlacius, S., Sulem, P., Geller, F., Aben, K.K., Stacey, S.N., Gudmundsson, J., Jakobsdottir, M., Bergthorsson, J.T., Sigurdsson, A. et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet., 40, 1307-1312.
10. Moore, L.E., Baris, D.R., Figueroa, J.D., Garcia-Closas, M., Karagas, M.R., Schwenn, M.R., Johnson, A.T., Lubin, J.H., Hein, D. W., Dagnall, C.L. et al. (2011) GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis, 32, 182-189.
11. Rothman, N., Garcia-Closas, M., Chatterjee, N., Malats, N., Wu, X., Figueroa, J.D., Real, F.X., Van Den Berg, D., Matullo, G., Baris, D. et al. (2010) A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat. Genet., 42, 978-984.
12. Wu, X., Ye, Y., Kiemeney, L.A., Sulem, P., Rafnar, T., Matullo, G., Seminara, D., Yoshida, T., Saeki, N., Andrew, A.S. et al. (2009) Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat. Genet., 41, 991-995.
13. Kiemeney, L.A., Sulem, P., Besenbacher, S., Vermeulen, S.H., Sigurdsson, A., Thorleifsson, G., Gudbjartsson, D.F., Stacey, S.N., Gudmundsson, J., Zanon, C. et al. (2010) A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat. Genet., 42, 415-419.
14. Rafnar, T., Vermeulen, S.H., Sulem, P., Thorleifsson, G., Aben, K.K., Witjes, J.A., Grotenhuis, A.J., Verhaegh, G.W., Hulsbergen-van de Kaa, C.A., Besenbacher, S. et al. (2011) European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum. Mol. Genet., 20, 4268-4281.
15. Tang, W., Fu, Y.P., Figueroa, J.D., Malats, N., Garcia-Closas, M., Chatterjee, N., Kogevinas, M., Baris, D., Thun, M., Hall, J.L. et al. (2012) Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum. Mol. Genet., 21, 1918-1930.
16. Rafnar, T., Sulem, P., Stacey, S.N., Geller, F., Gudmundsson, J., Sigurdsson, A., Jakobsdottir, M., Helgadottir, H., Thorlacius, S., Aben, K.K. et al. (2009) Sequence variants at the TERTCLPTM1L locus associate with many cancer types. Nat. Genet., 41, 221-227.
17. Matsuda, K., Takahashi, A., Middlebrooks, C.D., Obara, W., Nasu, Y., Inoue, K., Tamura, K., Yamasaki, I., Naya, Y., Tanikawa, C. et al. (2015) Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population. Hum. Mol. Genet., 24, 1177-1184.
18. Rafnar, T., Sulem, P., Thorleifsson, G., Vermeulen, S.H., Helgason, H., Saemundsdottir, J., Gudjonsson, S.A., Sigurdsson, A., Stacey, S.N., Gudmundsson, J. et al. (2014) Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer. Hum. Mol. Genet., 23, 5545-5557.
19. Figueroa, J.D., Ye, Y., Siddiq, A., Garcia-Closas, M., Chatterjee, N., Prokunina-Olsson, L., Cortessis, V.K., Kooperberg, C., Cussenot, O., Benhamou, S. et al. (2014) Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum. Mol. Genet., 23, 1387-1398.
20. Park, J.H., Wacholder, S., Gail, M.H., Peters, U., Jacobs, K.B., Chanock, S.J. and Chatterjee, N. (2010) Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat. Genet., 42, 570-575.
21. Figueroa, J.D., Han, S.S., Garcia-Closas, M., Baris, D., Jacobs, E. J., Kogevinas, M., Schwenn, M., Malats, N., Johnson, A., Purdue, M.P. et al. (2014) Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis, 35, 1737-1744.
22. Gudbjartsson, D.F., Helgason, H., Gudjonsson, S.A., Zink, F., Oddson, A., Gylfason, A., Besenbacher, S., Magnusson, G., Halldorsson, B.V., Hjartarson, E. et al. (2015) Large-scale whole-genome sequencing of the Icelandic population. Nat. Genet., 47, 435-444.
23. Ehret, G.B., Munroe, P.B., Rice, K.M., Bochud, M., Johnson, A. D., Chasman, D.I., Smith, A.V., Tobin, M.D., Verwoert, G.C., Hwang, S.J. et al. (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature, 478, 103-109.
24. The Cancer Genome Atlas Research Network. (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature, 507, 315-322.
25. Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E. et al. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal, 6, pl1.
26. Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E. et al. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov., 2, 401-404.
27. Ram, O., Goren, A., Amit, I., Shoresh, N., Yosef, N., Ernst, J., Kellis, M., Gymrek, M., Issner, R., Coyne, M. et al. (2011) Combinatorial patterning of chromatin regulators uncovered by genomewide location analysis in human cells. Cell, 147, 1628-1639.
28. Ward, L.D. and Kellis, M. (2012) HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res., 40, D930-D934.
29. Day-Williams, A.G., Southam, L., Panoutsopoulou, K., Rayner, N.W., Esko, T., Estrada, K., Helgadottir, H.T., Hofman, A., Ingvarsson, T., Jonsson, H. et al. (2011) Avariant in MCF2L is associated with osteoarthritis. Am. J. Hum. Genet., 89, 446-450.
30. Estrada, K., Styrkarsdottir, U., Evangelou, E., Hsu, Y.H., Duncan, E.L., Ntzani, E.E., Oei, L., Albagha, O.M., Amin, N., Kemp, J.P. et al. (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat. Genet., 44, 491-501.
31. Kung, A.W., Xiao, S.M., Cherny, S., Li, G.H., Gao, Y., Tso, G., Lau, K.S., Luk, K.D., Liu, J.M., Cui, B. et al. (2010) Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies. Am. J. Hum. Genet., 86, 229-239.
32. Garcia-Closas, M., Rothman, N., Figueroa, J.D., Prokunina-Olsson, L., Han, S.S., Baris, D., Jacobs, E.J., Malats, N., De Vivo, I., Albanes, D. et al. (2013) Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res., 73, 2211-2220.
33. Lee, S.H., Wray, N.R., Goddard, M.E. and Visscher, P.M. (2011) Estimating missing heritability for disease from genome-wide association studies. Am. J. Hum. Genet., 88, 294-305.
34. Yang, J., Benyamin, B., McEvoy, B.P., Gordon, S., Henders, A.K., Nyholt, D.R., Madden, P.A., Heath, A.C., Martin, N.G., Montgomery, G.W. et al. (2010) Common SNPs explain a large proportion of the heritability for human height. Nat. Genet., 42, 565-569.
35. Liu, Z., Adams, H.C. III and Whitehead, I.P. (2009) The rho-specific guanine nucleotide exchange factor Dbs regulates breast cancer cell migration. J. Biol. Chem., 284, 15771-15780.
36. Horii, Y., Beeler, J.F., Sakaguchi, K., Tachibana, M. and Miki, T. (1994) A novel oncogene, ost, encodes a guanine nucleotide exchange factor that potentially links Rho and Rac signaling pathways. EMBO J., 13, 4776-4786.
37. Fu, Y.P., Kohaar, I., Moore, L.E., Lenz, P., Figueroa, J.D., Tang, W., Porter-Gill, P., Chatterjee, N., Scott-Johnson, A., Garcia-Closas, M. et al. (2014) The 19q12 bladder cancerGWAS signal: association with cyclin E function and aggressive disease. Cancer Res., 74, 5808-5818.
38. Figueroa, J.D., Koutros, S., Colt, J.S., Kogevinas, M., Garcia-Closas, M., Real, F.X., Friesen, M.C., Baris, D., Stewart, P., Schwenn, M. et al. (2015) Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms. J. Natl. Cancer Inst., 107, doi: 10.1093/jnci/djv223.
39. Howie, B.N., Donnelly, P. and Marchini, J. (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet., 5, e1000529.
40. Abecasis, G.R., Auton, A., Brooks, L.D., DePristo, M.A., Durbin, R.M., Handsaker, R.E., Kang, H.M., Marth, G.T. and McVean, G. A. (2012) An integrated map of genetic variation from 1, 092 human genomes. Nature, 491, 56-65.
41. Fearnhead, P. (2006) SequenceLDhot: detecting recombination hotspots. Bioinformatics, 22, 3061-3066.
42. Fearnhead, P., Harding, R.M., Schneider, J.A., Myers, S. and Donnelly, P. (2004) Application of coalescent methods to reveal fine-scale rate variation and recombination hotspots. Genetics, 167, 2067-2081.